Aspen Health Education

Info

(19) 2003

TnI (Abbott Ax Sym)

Consecutive PCI (n = 471)

Death, MI, repeat PCI, CABG

445 d

TnI > 3 times ULN an independent predictor of long-term MACE

(22) 2002

TnI (Dade Dimension)

ACS (n = 481)

Death, MI, severe recurrent ischemia

90 d

Elevated TnI post-PCI associated with higher rate of death/MI

CAD, coronary artery disease; MACE, major adverse cardiac events; Tnl, troponin I; TnT, troponin T; TLR, target lesion revascularization.

CAD, coronary artery disease; MACE, major adverse cardiac events; Tnl, troponin I; TnT, troponin T; TLR, target lesion revascularization.

Concentration (ng/ml)

Fig. 5. Relationship between cardiac troponin I (cTnI) post-PCI and risk of subsequent death or MI through 90 d. (Data from ref. 18.)

Concentration (ng/ml)

Fig. 5. Relationship between cardiac troponin I (cTnI) post-PCI and risk of subsequent death or MI through 90 d. (Data from ref. 18.)

periprocedural myonecrosis (17,31,33,35), although other studies found similar rates of elevation post-PCI. None ofthese studies were adequately powered to determine whether one troponin assay was more predictive of adverse clinical outcomes after PCI.

Was this article helpful?